title: Epigenetic mechanisms of drug addiction.
abstract: Drug addiction involves potentially life-long behavioral abnormalities that are caused in vulnerable individuals by repeated exposure to a drug of abuse. The persistence of these behavioral changes suggests that long-lasting changes in gene expression, within particular regions of the brain, may contribute importantly to the addiction phenotype. Work over the past decade has demonstrated a crucial role for epigenetic mechanisms in driving lasting changes in gene expression in diverse tissues, including brain. This has prompted recent research aimed at characterizing the influence of epigenetic regulatory events in mediating the lasting effects of drugs of abuse on the brain in animal models of drug addiction. This review provides a progress report of this still early work in the field. As will be seen, there is robust evidence that repeated exposure to drugs of abuse induces changes within the brain's reward regions in three major modes of epigenetic regulation-histone modifications such as acetylation and methylation, DNA methylation, and non-coding RNAs. In several instances, it has been possible to demonstrate directly the contribution of such epigenetic changes to addiction-related behavioral abnormalities. Studies of epigenetic mechanisms of addiction are also providing an unprecedented view of the range of genes and non-genic regions that are affected by repeated drug exposure and the precise molecular basis of that regulation. Work is now needed to validate key aspects of this work in human addiction and evaluate the possibility of mining this information to develop new diagnostic tests and more effective treatments for addiction syndromes. This article is part of a Special Issue entitled 'NIDA 40th Anniversary Issue'.
authors: Fishberg Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1065, New York, NY 10029, USA. Electronic address: eric.nestler@mssm.edu.
authors: Eric J
authors: EJ
authors: Nestler
mesh_terms: D000818:Animals; D044127:Epigenesis, Genetic / Q000502:physiology*; D006801:Humans; D019966:Substance-Related Disorders / Q000235:genetics* / Q000503:physiopathology*
keywords: Cocaine; DNA methylation; Histone acetylation; Histone methylation; Opiates; microRNA
references: Epigenetics. 2011 Sep 1;6(9):1095-104
references: 21814037
references: Science. 2009 May 15;324(5929):929-30
references: 19372393
references: Nature. 2010 Jul 8;466(7303):197-202
references: 20613834
references: Biol Psychiatry. 2012 Sep 1;72(5):378-88
references: 22622000
references: J Cell Mol Med. 2009 Sep;13(9B):3591-615
references: 19602036
references: Neuropsychopharmacology. 2013 Jan;38(1):23-38
references: 22781841
references: J Neurosci. 2008 Jul 16;28(29):7344-9
references: 18632938
references: Alcohol Res. 2012;34(3):293-305
references: 23134045
references: Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):2647-52
references: 23297220
references: J Neuroimmune Pharmacol. 2012 Dec;7(4):808-19
references: 22068836
references: Genes Dev. 2011 Dec 1;25(23):2436-52
references: 22156206
references: Neuroreport. 2011 Aug 24;22(12):575-80
references: 21734607
references: J Neurosci. 2010 Sep 1;30(35):11735-44
references: 20810894
references: Nat Neurosci. 2010 Sep;13(9):1128-36
references: 20711186
references: Alcohol Clin Exp Res. 2012 Jan;36(1):61-71
references: 21790673
references: Biol Psychiatry. 2012 Nov 15;72(10):803-10
references: 22683090
references: Neuropsychopharmacology. 2010 Mar;35(4):913-28
references: 20010550
references: Ann N Y Acad Sci. 2011 Jan;1216:99-113
references: 21272014
references: Neuropharmacology. 2012 Jun;62(7):2309-19
references: 22349397
references: Neurosci Lett. 2008 Feb 13;432(1):54-7
references: 18164815
references: Science. 2001 Aug 10;293(5532):1074-80
references: 11498575
references: Neurosci Lett. 2008 Aug 15;441(1):72-6
references: 18599214
references: Science. 2010 Jan 8;327(5962):213-6
references: 20056891
references: J Neurosci. 2008 Sep 17;28(38):9342-8
references: 18799668
references: J Neurochem. 2011 Feb;116(3):459-66
references: 21128942
references: Nature. 2008 Jun 12;453(7197):879-84
references: 18496528
references: Mol Psychiatry. 2005 Apr;10(4):336-44
references: 15583701
references: Neuron. 2011 Aug 25;71(4):656-70
references: 21867882
references: Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):19186-91
references: 16380431
references: Neuron. 2005 Oct 20;48(2):303-14
references: 16242410
references: Trends Biochem Sci. 2006 Feb;31(2):89-97
references: 16403636
references: Nat Neurosci. 2013 Apr;16(4):434-40
references: 23475113
references: Neuron. 2012 Jan 12;73(1):108-20
references: 22243750
references: BMC Neurosci. 2008 Apr 28;9:42
references: 18442397
references: Neuropsychopharmacology. 2011 May;36(6):1149-64
references: 21307844
references: J Neurosci. 2012 Oct 3;32(40):13763-75
references: 23035088
references: Curr Top Behav Neurosci. 2013;13:87-126
references: 21877259
references: Front Psychiatry. 2012 Jun 14;3:60
references: 22712019
references: Neuropsychopharmacology. 2009 Mar;34(4):867-73
references: 18650805
references: RNA. 2011 Aug;17(8):1529-43
references: 21708909
references: Nat Neurosci. 2010 Sep;13(9):1137-43
references: 20729844
references: Neuropsychopharmacology. 2013 Jan;38(1):94-110
references: 22910457
references: Biol Psychiatry. 2011 Oct 15;70(8):763-769
references: 21820648
references: Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):3035-40
references: 21300862
references: Front Genet. 2012 Jun 22;3:106
references: 22737160
references: J Neurosci. 2012 Jul 25;32(30):10267-72
references: 22836260
references: Nat Rev Neurosci. 2007 May;8(5):355-67
references: 17453016
references: Nat Neurosci. 2011 Oct 30;14(12):1607-16
references: 22037496
references: Cell. 2011 Jan 7;144(1):16-26
references: 21215366
references: Behav Brain Res. 2007 Jul 19;181(1):76-84
references: 17477979
references: Mol Cell Neurosci. 2009 Dec;42(4):350-62
references: 19703567
references: Nature. 2012 Sep 6;489(7414):57-74
references: 22955616
references: Science. 2009 May 15;324(5929):930-5
references: 19372391
references: J Neurochem. 2012 Jan;120(2):202-9
references: 22043863
references: J Neurosci. 2008 May 28;28(22):5671-85
references: 18509028
references: Annu Rev Biochem. 2012;81:145-66
references: 22663078
references: J Neurosci. 2011 Nov 23;31(47):16941-8
references: 22114264
references: J Mol Neurosci. 2013 Feb;49(2):312-9
references: 22684622
references: Neuron. 2007 Nov 8;56(3):517-29
references: 17988634
references: Neuropsychopharmacology. 2010 Nov;35(12):2450-61
references: 20720536
references: Nat Genet. 2003 Mar;33 Suppl:245-54
references: 12610534
references: Nat Neurosci. 2010 Sep;13(9):1120-7
references: 20711185
references: Neuron. 2008 Jul 31;59(2):274-87
references: 18667155
references: PLoS One. 2012;7(10):e47527
references: 23110077
references: Nat Rev Neurosci. 2011 Oct 12;12(11):623-37
references: 21989194
references: J Neurosci. 2012 Nov 28;32(48):17454-64
references: 23197736
references: Neuron. 2009 May 14;62(3):335-48
references: 19447090
references: J Exp Med. 2010 Aug 30;207(9):1843-51
references: 20643829
references: J Neurochem. 2009 Mar;108(6):1323-35
references: 19183268
references: Biol Psychiatry. 2010 Jan 1;67(1):36-43
references: 19765687
references: Sci Transl Med. 2011 Nov 2;3(107):107ra109
references: 22049069
references: J Neurosci. 2005 Dec 7;25(49):11444-54
references: 16339038
references: Mol Cell Biol. 2012 Feb;32(3):619-32
references: 22144581
references: J Neurosci. 2013 Mar 6;33(10):4295-307
references: 23467346
references: Nat Protoc. 2011 Sep 29;6(10):1656-68
references: 21959244
references: Nat Neurosci. 2013 Jan;16(1):42-7
references: 23242310
references: Neuron. 2011 Dec 22;72(6):977-90
references: 22196333
references: Neuropsychopharmacology. 2008 Nov;33(12):2981-92
references: 18288092
references: J Neurosci. 2012 Feb 1;32(5):1884-97
references: 22302827
references: Neuroscience. 2008 Dec 2;157(3):644-55
references: 18848971